1887

Abstract

Endothelial cell-tropism- and leukocyte- (polymorphonuclear- and monocyte-) tropism (leukotropism) are two important biological properties shared by all recent clinical isolates of human cytomegalovirus (HCMV). These properties are lost during extensive propagation of HCMV isolates in human fibroblasts, as shown by reference laboratory-adapted strains AD169 and Towne. Here we show that strain AD169 may reacquire both properties , endothelial (both venous and arterial) cell-tropism preceding leukotropism (predominantly involving monocytes). Restriction fragment length polymorphism analysis and sequencing performed on the original virus inoculum from human fibroblasts and serial passages on endothelial cells confirmed virus identity. Thus, fundamental biological properties may be lost and reacquired according to the cell culture system employed. The lack of a 15 kb DNA fragment in the strain AD169 genome does not prevent the rescue of these biological functions, thus indicating that they are likely to be encoded by viral genes located elsewhere.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19055-0
2003-06-01
2024-10-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/6/vir841431.html?itemId=/content/journal/jgv/10.1099/vir.0.19055-0&mimeType=html&fmt=ahah

References

  1. Bolovan-Fritts C. A., Wiedeman J. A. 2001; Human cytomegalovirus strain Toledo lacks a virus-encoded tropism factor required for infection of aortic endothelial cells. J Infect Dis 184:1252–1261
    [Google Scholar]
  2. Bolovan-Fritts C. A., Wiedeman J. A. 2002; Mapping the viral genes determinants of endothelial cell tropism in human cytomegalovirus. J Clin Virol 25:S97–109
    [Google Scholar]
  3. Cha T.-H., Tom E., Kemble G. W., Duke G. M., Mocarski E. S., Spaete R. S. 1996; Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78–83
    [Google Scholar]
  4. Dargan D. J., Jamieson F. E., Maclean J., Dolan A., Addison C., McGeoch D. J. 1997; The published DNA sequence of human cytomegalovirus strain AD169 lack 929 base pairs affecting genes UL42 and UL43. J Virol 71:9833–9836
    [Google Scholar]
  5. Fish K. N., Soderberg-Naucler C., Mills L. K., Stenglein S., Nelson J. A. 1998; Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72:5661–5668
    [Google Scholar]
  6. Gerna G., Revello M. G., Percivalle E., Zavattoni M., Parea M., Battaglia M. 1990; Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 28:2681–2688
    [Google Scholar]
  7. Gerna G., Revello M. G., Percivalle E., Morini F. 1992; Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 30:1232–1237
    [Google Scholar]
  8. Gerna G., Percivalle E., Torsellini M., Revello M. G. 1998a; Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J Clin Microbiol 36:3585–3589
    [Google Scholar]
  9. Gerna G., Zavattoni M., Baldanti F., Sarasini A., Chezzi L., Grossi P., Revello M. G. 1998b; Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 65:1378–1385
    [Google Scholar]
  10. Gerna G., Percivalle E., Baldanti F., Sozzani S., Lanzarini P., Genini E., Lilleri D., Revello M. G. 2000; Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 74:5629–5638
    [Google Scholar]
  11. Gerna G., Percivalle E., Baldanti F., Revello M. G. 2002a; Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus. J Med Virol 66:335–339
    [Google Scholar]
  12. Gerna G., Percivalle E., Sarasini A., Baldanti F., Revello M. G. 2002b; The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro . J Gen Virol 83:1993–2000
    [Google Scholar]
  13. Gerna G., Percivalle E., Sarasini A., Revello M. G. 2002c; Human cytomegalovirus and human umbilical vein endothelial cells: restriction of primary isolation to blood samples and susceptibilities of clinical isolates from other sources to adaptation. J Clin Microbiol 40:233–238
    [Google Scholar]
  14. Kahl M., Siegel-Axel D., Stenglein S., Jahn G., Sinzger C. 2000; Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol 74:7628–7635
    [Google Scholar]
  15. MacCormac L. P., Grundy J. E. 1999; Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne or Davis strains. J Med Virol 57:298–307
    [Google Scholar]
  16. Mocarski E. S., Prichard M. N., Tan C. S., Brown J. M. 1997; Reassessing the organization of the UL42–UL43 region of the human cytomegalovirus strain AD169 genome. Virology 239:169–175
    [Google Scholar]
  17. Penfold M. E. T., Dairaghi D. J., Duke G. M., Saederup N., Mocarski E. S., Kemble G. W., Schall T. 1999; Cytomegalovirus encodes a potent chemokine. Proc Natl Acad Sci U S A 96:9839–9844
    [Google Scholar]
  18. Plotkin S. A., Furukawa T., Zygraich N., Huygelen C. 1975; Candidate cytomegalovirus strain for human vaccination. Infect Immun 12:521–527
    [Google Scholar]
  19. Revello M. G., Percivalle E., Arbustini E., Pardi R., Sozzani S., Gerna G. 1998; In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J Clin Invest 101:2686–2692
    [Google Scholar]
  20. Revello M. G., Baldanti F., Percivalle E., Sarasini A., De-Giuli L., Genini E., Lilleri D., Labò N., Gerna G. 2001; In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol 82:1429–1438
    [Google Scholar]
  21. Rowe W. P., Hartley J. W., Waterman S., Turner H. C., Hubner R. J. 1956; Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med 92:418–422
    [Google Scholar]
  22. Sinzger C., Kahl M., Laib K., Klingel K., Rieger P., Plachter B., Jahn G. 2000; Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J Gen Virol 81:3021–3035
    [Google Scholar]
  23. Slobbe van Drunen M. E., Hendrickx A. T., Vossen R. C., Speel E. J., Van Dam Mieras M. C., Bruggeman C. A. 1998; Nuclear import as a barrier to infection of human umbilical vein endothelial cells by human cytomegalovirus strain AD169. Virus Res 56:149–156
    [Google Scholar]
  24. Weller T. H., Macaulay J. C., Craig J. M., Wirth P. 1957; Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 94:4–12
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.19055-0
Loading
/content/journal/jgv/10.1099/vir.0.19055-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error